Meplazumab
Meplazumab is a human IgG1 monoclonal antibody (mAb) targeting Basigin/CD147. Meplazumab can be used in COVID-19 pneumonia, Coronary artery disease and Malaria research. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
Product Name Alternative
HcHAb18
UNSPSC
12352203
Target
SARS-CoV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Purity
99.25
Smiles
[Meplazumab]
References & Citations
[1]Bian H, et al. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial. Signal Transduct Target Ther. 2021 May 17;6 (1) :194.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC225301L3V 200 µL
RABL2B (NM_001130923) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
MBS6209864-01 0.1 mL
Streptococcus pneumoniae, Common C-polysaccharide (MaxLight 550)
Ask
View Details MBS6209864-02 5x 0.1 mL
Streptococcus pneumoniae, Common C-polysaccharide (MaxLight 550)
Ask
View Details 031569-ML405 100 µL
ACTBL3, NT (POTEKP, ACTBL3, Putative beta-actin-like protein 3, Kappa-actin, POTE ankyrin domain family member K) (MaxLight 405) discontinued
Ask
View Details